Role of kallistatin in pediatric patients with pulmonary arterial hypertension
TURKISH JOURNAL OF PEDIATRICS, cilt.62, sa.3, ss.405-410, 2020 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 62 Sayı: 3
- Basım Tarihi: 2020
- Doi Numarası: 10.24953/turkjped.2020.03.007
- Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.405-410
- Anahtar Kelimeler: kallistatin, pulmonary hypertension, TNF alpha, IL-10
- Erciyes Üniversitesi Adresli: Evet
Özet
Background and objectives. Kallistatin, a serine proteinase inhibitor, exerts its effect by vascular repair, angiogenesis inhibition, strong vasodilation, inhibition of vascular endothelial growth factor (VEGF), anti-inflammation, and anti-apoptosis. We hypothesized as to whether it has a protective role in pulmonary arterial hypertension (PAH).